DE3766028D1 - 1-hydroxy-5-oxo-5h-pyrido(3,2-a)-phenoxazin-3-carbonsaeureester. - Google Patents

1-hydroxy-5-oxo-5h-pyrido(3,2-a)-phenoxazin-3-carbonsaeureester.

Info

Publication number
DE3766028D1
DE3766028D1 DE8787110051T DE3766028T DE3766028D1 DE 3766028 D1 DE3766028 D1 DE 3766028D1 DE 8787110051 T DE8787110051 T DE 8787110051T DE 3766028 T DE3766028 T DE 3766028T DE 3766028 D1 DE3766028 D1 DE 3766028D1
Authority
DE
Germany
Prior art keywords
phenoxazine
pyrido
oxo
hydroxy
acid ester
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8787110051T
Other languages
English (en)
Inventor
Hideo Terayama
Jun Inoue
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Senju Pharmaceutical Co Ltd
Original Assignee
Senju Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharmaceutical Co Ltd filed Critical Senju Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE3766028D1 publication Critical patent/DE3766028D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/06Peri-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/12Ophthalmic agents for cataracts

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DE8787110051T 1986-07-15 1987-07-11 1-hydroxy-5-oxo-5h-pyrido(3,2-a)-phenoxazin-3-carbonsaeureester. Expired - Fee Related DE3766028D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61166066A JPS6322584A (ja) 1986-07-15 1986-07-15 1−ハイドロキシ−5−オキソ−5H−ピリド〔3,2−a〕フエノキサジン−3−カルボン酸エステル類

Publications (1)

Publication Number Publication Date
DE3766028D1 true DE3766028D1 (de) 1990-12-13

Family

ID=15824343

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787110051T Expired - Fee Related DE3766028D1 (de) 1986-07-15 1987-07-11 1-hydroxy-5-oxo-5h-pyrido(3,2-a)-phenoxazin-3-carbonsaeureester.

Country Status (12)

Country Link
US (1) US4820837A (de)
EP (1) EP0254167B1 (de)
JP (1) JPS6322584A (de)
KR (1) KR950008316B1 (de)
CN (1) CN1019299B (de)
AT (1) ATE58141T1 (de)
CA (1) CA1311477C (de)
DE (1) DE3766028D1 (de)
ES (1) ES2031477T3 (de)
GR (1) GR3001065T3 (de)
HU (1) HU196211B (de)
SU (1) SU1628858A3 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU635045B2 (en) * 1989-07-20 1993-03-11 Asai Germanium Research Institute Co., Ltd Agent for preventing and treating opacity of lens
CN108558906A (zh) * 2018-05-21 2018-09-21 日照市普达医药科技有限公司 一种治疗白内障药物苯并吩噁嗪类化合物及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59520B2 (ja) * 1974-07-19 1984-01-07 センジユセイヤク カブシキガイシヤ 1− ハイドロキシ −5− オキソ −5h− ピリド ( 3,2−a ) フエノキサジン −3− カルボンサン オヨビ ソノユウドウタイノセイセイホウ
JPS5270014A (en) * 1975-12-05 1977-06-10 Senju Pharma Co Stabilization of pyrido*3*22a*phenoxadine compounds
SE448091B (sv) * 1977-12-15 1987-01-19 Roussel Uclaf Nya 2-/(4-kinolinyl)-amino/-5-fluorbensoesyraderivat, forfarande for framstellning derav samt farmaceutiska kompositioner innehallande dessa derivat
US4369184A (en) * 1980-01-24 1983-01-18 Janssen Pharmaceutica N.V. 1-(Cyclohexyl)-4-aryl-4-piperidinecarboxylic acid derivatives

Also Published As

Publication number Publication date
CN87104927A (zh) 1988-02-03
CN1019299B (zh) 1992-12-02
SU1628858A3 (ru) 1991-02-15
ATE58141T1 (de) 1990-11-15
HU196211B (en) 1988-10-28
CA1311477C (en) 1992-12-15
JPH0236596B2 (de) 1990-08-17
ES2031477T3 (es) 1992-12-16
EP0254167A1 (de) 1988-01-27
US4820837A (en) 1989-04-11
EP0254167B1 (de) 1990-11-07
GR3001065T3 (en) 1992-03-20
KR880001666A (ko) 1988-04-26
JPS6322584A (ja) 1988-01-30
KR950008316B1 (ko) 1995-07-27
HUT45062A (en) 1988-05-30

Similar Documents

Publication Publication Date Title
NO905572D0 (no) Fremgangsmaate for fremstilling av peptidforbindelser.
ES2053587T3 (es) Nuevos derivados de bencimidazoles activos como agentes anti-ulcera.
DK0430045T3 (da) Ascorbinsyretocopherylphosphatdiestere til hæmning af Maillards reaktion
ES2063452T3 (es) Preparacion y uso de esteres y derivados de n-yodopropargil oxicarbonil aminoacido como agentes antimicrobianos.
ES2031569T3 (es) Derivados de acidos quinolinocarboxilicos.
DE3370585D1 (en) Use of aminophenylacetic acid derivatives for the manufacture of an immunomodulating medical preparation
SE8604950L (sv) Demensforbettrande och terapeutiska medel
ATE110721T1 (de) 2-alkyl-3-benzoylbenzofurane und diese enthaltende pharmazeutische zusammensetzungen.
ES2038710T3 (es) Un procedimiento de preparacion de un derivado de benzoxazina y su utilizacion.
DE3766028D1 (de) 1-hydroxy-5-oxo-5h-pyrido(3,2-a)-phenoxazin-3-carbonsaeureester.
AU3624089A (en) Analgesic phenothiazine derivatives
ES8206537A1 (es) Procedimiento para la obtencion de nuevos derivados de la tiazolo (3,2-a) pirimidina
DE3882623D1 (de) Phosphorsaeurediester und salze davon.
ES2059451T3 (es) Derivados de naftotiazepina y su procedimiento de preparacion.
ES449446A1 (es) Un procedimiento para la produccion de acidos 1-oxo-1h-6-pi-peridinogicamente activos y esteres de los mismos.
KR950017967A (ko) 피리다지논 유도체, 그의 제조법 및 그의 용도
ATE81465T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
FR2359836A1 (fr) Ethers de zearaline utiles comme agents promoteurs de la croissance

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee